news Glycomimetics could prevent COVID-19 from infecting human cells 21 April 2020 | By Hannah Balfour (Drug Target Review) Glycomimetics, a novel class of antivirals, prevented influenza, herpes viruses and papillomaviruses from infecting cells in animal models and could show similar efficacy against COVID-19.